Posts in the “Press Releases Press Releases” category:

Myriad Genetics’ myPlan™ Lung Cancer Test Meets Primary Clinical Endpoint

mygn-myriad-genetics-logo
Posted by Samantha Powell on September 24th, 2013 |

Myriad Genetics’ myPlan™ Lung Cancer Test Meets Primary Clinical Endpoint Verification Study Published in the Journal Clinical Cancer Research SALT LAKE CITY, Utah, Sept. 24, 2013 – Myriad Genetics, Inc. (NASDAQ: MYGN) today announced new data published in Clinical Cancer Research that showed the myPlan Lung Cancer test is a significant predictor of lung cancer […]

Garland Raises More Than $40,000 for the Bonnie J. Addario Lung Cancer Foundation

Posted by Samantha Powell on August 7th, 2013 |

News Headline: Garland Raises More Than $40,000 for the Bonnie J. Addario Lung Cancer Foundation Date: 8/7/13 Outlet Full Name: PR Web Author Name: N/A http://www.prweb.com/releases/spirit/week/prweb11005602.htm Cleveland, Ohio (PRWEB) August 07, 2013 The Garland Company, Inc., a local employee-owned manufacturer of high-performance solutions for the commercial building envelope, raised more than $40,000 to support The […]

More Research Needs to Be Done On Treatment For Lung Cancer Among Non-Smoking Women

Posted by Samantha Powell on June 26th, 2013 |

cheap longchamp online By Sam Goodwin / Jun 26, 2013 An estimated 516,000 women worldwide are affected by lung cancer and 100,000 of these women are from the United States. Up until now, women with lung cancer have been given the same treatment as men. However, numerous studies have highlighted different characteristics of lung cancer […]

New National Public Opinion Poll Shows Majority of Americans Would Participate in Clinical Trials if Recommended by Their Doctor

Posted by Samantha Powell on June 12th, 2013 | No comments

Only Small Percentage say Health Care Professionals Have Ever Talked to Them about Medical Research ALEXANDRIA, Va.-June 12, 2013 – More than two-thirds (72%) of Americans say it’s likely they would participate in a clinical trial if recommended by their doctor, but only 22% say a doctor or other health care professional has ever talked […]

Primary Progression-Free Survival Endpoint Met in Phase III Study of Nintedanib Plus Docetaxel in Second-Line Advanced NSCLC

Posted by Samantha Powell on June 3rd, 2013 | No comments

Ridgefield, CT, June 3, 2013 – Boehringer Ingelheim Pharmaceuticals, Inc.(BIPI) today announced results from the Phase III LUME-Lung 1 study showing that the addition of the investigational oncology compound nintedanib* to docetaxel improved progression-free survival (PFS) – the primary endpoint –as a second-line treatment in patients with advanced non-small cell lung cancer (NSCLC) compared to […]

San Francisco’s Free Comedy Day: The 33rd Time’s the Charm!

Posted by Samantha Powell on April 25th, 2013 |

FOR IMMEDIATE RELEASE April 25, 2013 CONTACT: KATZMANN CREATIONS katzmann@comedyday.com / 510-839-3280 http://www.ComedyDay.org Media Kit: http://www.comedyday.org/about/media CALENDAR EDITORS: SEE BELOW San Francisco’s Free Comedy Day: The 33rd Time’s the Charm! Comedy Day, presented on Sunday, September 15 in Golden Gate Park, is dedicated to combating violence in our communities and to the eradication of lung […]